Now Approved

The mission in BPDCN:
Remission, Right Where You Belong

In a clinical trial that, in part, included 33 people who received
DECNUPAZ as their first treatment for BPDCN with no central
nervous system involvement:

  • 70% achieved complete remission. Of the people who achieved
    complete remission, half were estimated to still respond to
    DECNUPAZ for at least 9.7 months

Remission or complete remission means that all signs of cancer
have disappeared in response to treatment, but there may be
some skin abnormalities that remain.

Introducing DECNUPAZ: The first and only
FDA‍-‍approved treatment for BPDCN that's
given outpatient from the start, once every 21 days. No hospital stay for infusions can mean more time to focus on what matters during treatment.

See how DECNUPAZ is given

Actual clinical time may vary, including premedication and
post-infusion monitoring.

The mission in BPDCN:
Remission, Right Where You Belong

In a clinical trial that featured 33 people who received DECNUPAZ as
their first treatment for BPDCN, 70% achieved complete remission.
Of the people who achieved complete remission, half were estimated to
still remain in remission for at least 9.7 months. Remission or complete
remission means that all signs of cancer have disappeared in response to 
treatment, but there may be some skin abnormalities that remain.

DECNUPAZ: The first and only FDA-approved treatment that's given outpatient from the start, once every 21 days. No hospital stay for infusions can mean more time to focus on what matters during treatment.

See how DECNUPAZ is given

Actual clinical time may vary, including premedication and
post-infusion monitoring.

Now Approved

The mission in BPDCN:
Remission, Right Where You Belong

In a clinical trial that, in part,
included 33 people who received
DECNUPAZ as their first treatment
for BPDCN with no central nervous
system involvement:

  • 70% achieved complete remission.
    Of the people who achieved
    complete remission, half were
    estimated to still respond to
    DECNUPAZ for at least 9.7 months

Remission or complete remission
means that all signs of cancer have
disappeared in response to
treatment, but there may be some
skin abnormalities that remain.

Introducing DECNUPAZ:The first and only
FDA-approved treatment for BPDCN that's given
outpatient from the start, once every 21 days.
No hospital stay for infusions can mean more
time to focus on what matters during treatment.

See how DECNUPAZ is given

Actual clinical time may vary, including premedication
and post-infusion monitoring.

The mission in BPDCN:
Remission, Right Where You Belong

DECNUPAZ: The first and only FDA-approved treatment that's given outpatient from the start, once every 21 days. No hospital stay for infusions can mean more time to focus on what matters during treatment.

Actual clinical time may vary, including premedication and post-infusion monitoring.

See how DECNUPAZ is given

In a clinical trial that featured 33 people who
received DECNUPAZ as their first treatment for BPDCN, 70% achieved complete remission. Of the people who achieved complete remission, half were estimated to still remain in remission for at least 9.7 months. Remission or complete remission means that all signs of cancer have disappeared in response to treatment, but there may be some skin abnormalities that remain.

See what DECNUPAZ, a NEW treatment for BPDCN, could mean for you

See what DECNUPAZ, a treatment for BPDCN, could mean for you

What is DECNUPAZ?

DECNUPAZ is a prescription medicine used to treat adults with blastic plasmacytoid dendritic cell neoplasm (BPDCN).
It is not known if DECNUPAZ is safe and effective in children.

Possibility for remission

Learn more about clinical trial results in people who received DECNUPAZ as a first treatment, and in people who either relapsed after a previous treatment or did not respond to previous treatment. See what to expect with treatment.

VIEW RESULTS

First BPDCN treatment given as an outpatient infusion from the start

See how DECNUPAZ is given, and learn what to expect before and after each infusion.

VIEW TREATMENT PLAN

Questions to ask your doctor

If you or a loved one is starting treatment with DECNUPAZ, you may have many questions. Use our Doctor Discussion Guide to help talk openly with your healthcare provider or care team.

DOWNLOAD GUIDE

BPDCN=blastic plasmacytoid dendritic cell neoplasm

Find a BPDCN Specialist

BPDCN can rapidly progress, so it is important to start treatment as soon as possible.
Healthcare providers who specialize in BPDCN can help you get timely treatment.

FIND A BPDCN SPECIALIST
About BPDCN